Peptide Therapeutics

A scalable solution for de novo peptide design, addressing unmet medical needs

Proprietary AI for peptide engineering

Using purpose-built supercomputing facilities and innovative AI algorithms, we explore uncharted chemical space to engineer peptides—the next-generation medicines—for previously undruggable targets and areas of interest.

Physics based modeling techniques

We systematically identify the finest binding peptides—synthesizable and selective, with optimized physicochemical and pharmacological properties. This is achieved through the rigorous application of state-of-the-art in-silico and physics-based modelling techniques.

Diverse and optimised

Our AI generative model produces a diverse array of peptides tailored to the therapeutic area, ultimately optimizing and screening out potentially toxic candidates.

Peptide Image

Stay tuned for more exciting work and updates on Peptide Therapeutics!

Why Medvolt

Accelerate Discovery

Medvolt's AI-powered platform cuts pre-clinical discovery time by 3x, reduces costs by 15x and lowers failure risk by 25%. Enhance your R&D efficiency with our in silico tools.

High-Throughput Data

Enrich your research with Medvolt's proprietary, gold-standard, high-throughput proprietary datasets. Our AI and NLP solutions deliver speed, precision and scalability.

Expert Collaboration

Our experienced, tech-driven team collaborates globally with leading pharma and biotech companies, ensuring impactful, scalable solutions.